Neil Gallagher - May 1, 2025 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Director
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Neil Gallagher
Stock symbol
FHTX
Transactions as of
May 1, 2025
Transactions value $
$208,000
Form type
4
Date filed
5/2/2025, 04:04 PM
Previous filing
Feb 12, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gallagher Neil Director 500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE /s/ Michael LaCascia, Attorney-in-Fact for Neil Gallagher 2025-05-02 0001972849

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Options (Right to buy) Award $208K +50K $4.16 50K May 1, 2025 Common Stock 50K $4.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest as to one-third of the underlying shares of common stock on each of the first three anniversaries of the date of grant, subject to the recipient's continuing service on the board of directors.